Clinical Trials Browser

Withdrawn × Interventional × Radiodermatitis × Clear all

NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

Phase NA Withdrawn

Breast Neoplasms, Radiodermatitis

NCT04692389 2022-02-08

Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.

Phase NA Withdrawn

Neoplasms, Pain, Radiodermatitis

NCT04593914 2021-11-03

CASP-ORL

Phase NA Withdrawn

Head and Neck Neoplasms, Radiation Injuries, Radiodermatitis, Skin Diseases

NCT01544504 2012-05-28

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

Phase 1/2 Withdrawn

Radiodermatitis